{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:07:01Z","timestamp":1795028821327,"version":"4.10.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172489"],"award-info":[{"award-number":["82172489"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Estrogen deficiency after menopause accelerates bone loss by stimulating osteoclast formation and activity, but the molecular pathways that link estrogen signaling to osteoclast regulation remain incompletely defined. Here, we identify the sialyltransferase ST3GAL-I as a key mediator of RANKL-induced osteoclastogenesis. RANKL activates c-FOS to drive ST3GAL1 transcription, whereas estrogen-bound ER\u03b1 competes with TRAF6 and suppresses this c-FOS\u2013dependent induction. In a clinical cohort of pre-menopausal and post-menopausal women with or without osteoporosis, serum total and \u03b1-2,3-linked sialic acid levels increased with age and were highest in post-menopausal osteoporotic patients. Single-cell RNA sequencing of human bone revealed that osteoclasts form a prominent cluster only after menopause, where FOS, CTSK, and ST3GAL1 are strongly co-expressed, and the estrogen-responsive gene PGR is down-regulated. Additionally, in vivo experiments showed that sialidase treatment in estrogen-deficient models effectively reduced osteoclast-mediated bone loss, mimicking the effects of estradiol. These findings define a direct molecular link between loss of estrogen and activation of a FOS\u2013ST3GAL1 sialylation pathway in osteoclasts, providing mechanistic insight into the enhanced bone resorption characteristic of post-menopausal osteoporosis.<\/jats:p>","DOI":"10.1038\/s41413-025-00498-x","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:58:45Z","timestamp":1770879525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Estradiol regulates osteoclast sialylation via ST3Gal1 in postmenopausal osteoporosis"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6983-6354","authenticated-orcid":false,"given":"Ce","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xialin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuquan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"498_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00198-004-1762-7","volume":"16","author":"P Lips","year":"2005","unstructured":"Lips, P. & van Schoor, N. M. Quality of life in patients with osteoporosis. Osteoporos. Int. 16, 447\u2013455 (2005).","journal-title":"Osteoporos. Int."},{"key":"498_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.69","volume":"2","author":"R Eastell","year":"2016","unstructured":"Eastell, R. et al. Postmenopausal osteoporosis. Nat. Rev. Dis. Prim. 2, 16069 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"498_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","volume":"29","author":"TP van Staa","year":"2001","unstructured":"van Staa, T. P., Dennison, E. M., Leufkens, H. G. & Cooper, C. Epidemiology of fractures in England and Wales. Bone 29, 517\u2013522 (2001).","journal-title":"Bone"},{"key":"498_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.0105-2896.2005.00334.x","volume":"208","author":"JA Clowes","year":"2005","unstructured":"Clowes, J. A., Riggs, B. L. & Khosla, S. The role of the immune system in the pathophysiology of osteoporosis. Immunol. Rev. 208, 207\u2013227 (2005).","journal-title":"Immunol. Rev."},{"key":"498_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrendo.2013.179","volume":"9","author":"SC Manolagas","year":"2013","unstructured":"Manolagas, S. C., O\u2019Brien, C. A. & Almeida, M. The role of estrogen and androgen receptors in bone health and disease. Nat. Rev. Endocrinol. 9, 699\u2013712 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"498_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jbmr.5650110307","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero, P., Sornay-Rendu, E., Chapuy, M. C. & Delmas, P. D. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J. Bone Miner. Res. 11, 337\u2013349 (1996).","journal-title":"J. Bone Miner. Res."},{"key":"498_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165\u2013176 (1998).","journal-title":"Cell"},{"key":"498_CR8","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda, H. et al. Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc. Natl. Acad. Sci. USA 95, 3597\u20133602 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"498_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.292.4.490","volume":"292","author":"LC Hofbauer","year":"2004","unstructured":"Hofbauer, L. C. & Schoppet, M. Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases. JAMA. 292, 490\u2013495 (2004).","journal-title":"JAMA"},{"key":"498_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1172\/JCI28550","volume":"116","author":"MN Weitzmann","year":"2006","unstructured":"Weitzmann, M. N. & Pacifici, R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest. 116, 1186\u20131194 (2006).","journal-title":"J. Clin. Invest."},{"key":"498_CR11","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1172\/JCI200317215","volume":"111","author":"G Eghbali-Fatourechi","year":"2003","unstructured":"Eghbali-Fatourechi, G. et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111, 1221\u20131230 (2003).","journal-title":"J. Clin. Invest."},{"key":"498_CR12","doi-asserted-by":"publisher","first-page":"7829","DOI":"10.1073\/pnas.130200197","volume":"97","author":"NK Shevde","year":"2000","unstructured":"Shevde, N. K., Bendixen, A. C., Dienger, K. M. & Pike, J. W. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc. Natl. Acad. Sci. USA 97, 7829\u20137834 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"498_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.186.4.489","volume":"186","author":"T Kameda","year":"1997","unstructured":"Kameda, T. et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J. Exp. Med. 186, 489\u2013495 (1997).","journal-title":"J. Exp. Med."},{"key":"498_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1210\/jc.2013-2905","volume":"99","author":"FZ Stanczyk","year":"2014","unstructured":"Stanczyk, F. Z. & Clarke, N. J. Measurement of estradiol-challenges ahead. J. Clin. Endocrinol. Metab. 99, 56\u201358 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"498_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.molmed.2008.06.002","volume":"14","author":"A Varki","year":"2008","unstructured":"Varki, A. Sialic acids in human health and disease. Trends Mol. Med. 14, 351\u2013360 (2008).","journal-title":"Trends Mol. Med."},{"key":"498_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1046\/j.1365-2141.2003.04786.x","volume":"124","author":"SM Crean","year":"2004","unstructured":"Crean, S. M. et al. N-linked sialyated sugar receptors support haematopoietic cell-osteoblast adhesions. Br. J. Haematol. 124, 534\u2013546 (2004).","journal-title":"Br. J. Haematol."},{"key":"498_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/glycob\/9.6.557","volume":"9","author":"OT Keppler","year":"1999","unstructured":"Keppler, O. T. et al. Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1\/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology 9, 557\u2013569 (1999).","journal-title":"Glycobiology"},{"key":"498_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1189\/jlb.0503241","volume":"75","author":"NM Stamatos","year":"2004","unstructured":"Stamatos, N. M., Curreli, S., Zella, D. & Cross, A. S. Desialylation of glycoconjugates on the surface of monocytes activates the extracellular signal-related kinases ERK 1\/2 and results in enhanced production of specific cytokines. J. Leukoc. Biol. 75, 307\u2013313 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"498_CR19","first-page":"2455","volume":"20","author":"OG Olaru","year":"2020","unstructured":"Olaru, O. G., Constantin, G. I. & Pena, C. M. Variation of total serum sialic acid concentration in postmenopausal women. Exp. Ther. Med. 20, 2455\u20132459 (2020).","journal-title":"Exp. Ther. Med."},{"key":"498_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bone.2007.03.016","volume":"41","author":"M Takahata","year":"2007","unstructured":"Takahata, M. et al. Sialylation of cell surface glycoconjugates is essential for osteoclastogenesis. Bone 41, 77\u201386 (2007).","journal-title":"Bone"},{"key":"498_CR21","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1210\/jc.2003-032187","volume":"89","author":"VV Valimaki","year":"2004","unstructured":"Valimaki, V. V. et al. Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men. J. Clin. Endocrinol. Metab. 89, 3785\u20133789 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"498_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.766606","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Studies and application of sialylated milk components on regulating neonatal gut microbiota and health. Front. Nutr. 8, 766606 (2021).","journal-title":"Front. Nutr."},{"key":"498_CR23","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.yexcr.2009.01.014","volume":"315","author":"LJ Robinson","year":"2009","unstructured":"Robinson, L. J. et al. Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6. Exp. Cell Res. 315, 1287\u20131301 (2009).","journal-title":"Exp. Cell Res."},{"key":"498_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s13238-018-0597-5","volume":"10","author":"F Li","year":"2019","unstructured":"Li, F. & Ding, J. Sialylation is involved in cell fate decision during development, reprogramming and cancer progression. Protein Cell 10, 550\u2013565 (2019).","journal-title":"Protein Cell"},{"key":"498_CR25","doi-asserted-by":"publisher","first-page":"e10690","DOI":"10.1002\/jbm4.10690","volume":"6","author":"I Ota","year":"2022","unstructured":"Ota, I., Ota, Y., Ota, K., Eda, H. & Ohta, H. TRACP-5b\/BAP score after 3 months of treatment with combined SERM\/E2 therapy can predict changes in lumbar spine bone mineral density after 1 year of treatment in early postmenopausal osteopenia. JBMR Plus 6, e10690 (2022).","journal-title":"JBMR Plus"},{"key":"498_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13075-018-1586-z","volume":"20","author":"C Engdahl","year":"2018","unstructured":"Engdahl, C. et al. Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women. Arthritis Res. Ther. 20, 84 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"498_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7651","volume":"6","author":"U Harre","year":"2015","unstructured":"Harre, U. et al. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat. Commun. 6, 6651 (2015).","journal-title":"Nat. Commun."},{"key":"498_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13009","volume":"93","author":"E Sehic","year":"2021","unstructured":"Sehic, E. et al. Immunoglobulin G complexes without sialic acids enhance osteoclastogenesis but do not affect arthritis-mediated bone loss. Scand. J. Immunol. 93, e13009 (2021).","journal-title":"Scand. J. Immunol."},{"key":"498_CR29","doi-asserted-by":"publisher","first-page":"17493","DOI":"10.1074\/jbc.M111.324194","volume":"287","author":"N Ishida-Kitagawa","year":"2012","unstructured":"Ishida-Kitagawa, N. et al. Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12). J. Biol. Chem. 287, 17493\u201317502 (2012).","journal-title":"J. Biol. Chem."},{"key":"498_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41413-022-00186-0","volume":"10","author":"C Dou","year":"2022","unstructured":"Dou, C. et al. Sialylation of TLR2 initiates osteoclast fusion. Bone Res. 10, 24 (2022).","journal-title":"Bone Res."},{"key":"498_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.002","volume":"57","author":"E Maverakis","year":"2015","unstructured":"Maverakis, E. et al. Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review. J. Autoimmun. 57, 1\u201313 (2015).","journal-title":"J. Autoimmun."},{"key":"498_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102804","volume":"20","author":"X Zhou","year":"2021","unstructured":"Zhou, X. et al. Antibody glycosylation in autoimmune diseases. Autoimmun. Rev. 20, 102804 (2021).","journal-title":"Autoimmun. Rev."},{"key":"498_CR33","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1073\/pnas.1507706113","volume":"113","author":"M Perdicchio","year":"2016","unstructured":"Perdicchio, M. et al. Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells. Proc. Natl. Acad. Sci. USA 113, 3329\u20133334 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"498_CR34","first-page":"224","volume":"49","author":"W Li","year":"2019","unstructured":"Li, W. et al. Investigation of the potential use of sialic acid as a biomarker for rheumatoid arthritis. Ann. Clin. Lab Sci. 49, 224\u2013231 (2019).","journal-title":"Ann. Clin. Lab Sci."},{"key":"498_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22365-z","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Loss of alpha2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis. Nat. Commun. 12, 2343 (2021).","journal-title":"Nat. Commun."},{"key":"498_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06517.x","volume":"1253","author":"A Varki","year":"2012","unstructured":"Varki, A. & Gagneux, P. Multifarious roles of sialic acids in immunity. Ann. N. Y. Acad. Sci. 1253, 16\u201336 (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"498_CR37","doi-asserted-by":"publisher","first-page":"818736","DOI":"10.3389\/fimmu.2022.818736","volume":"13","author":"R Vattepu","year":"2022","unstructured":"Vattepu, R., Sneed, S. L. & Anthony, R. M. Sialylation as an important regulator of antibody function. Front. Immunol. 13, 818736 (2022).","journal-title":"Front. Immunol."},{"key":"498_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41420-024-02180-3","volume":"10","author":"W Zhu","year":"2024","unstructured":"Zhu, W., Zhou, Y., Guo, L. & Feng, S. Biological function of sialic acid and sialylation in human health and disease. Cell Death Discov. 10, 415 (2024).","journal-title":"Cell Death Discov."},{"key":"498_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"PR Crocker","year":"2007","unstructured":"Crocker, P. R., Paulson, J. C. & Varki, A. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7, 255\u2013266 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"498_CR40","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3389\/fimmu.2018.02807","volume":"9","author":"J Lubbers","year":"2018","unstructured":"Lubbers, J., Rodriguez, E. & van Kooyk, Y. Modulation of immune tolerance via siglec-sialic acid interactions. Front. Immunol. 9, 2807 (2018).","journal-title":"Front. Immunol."},{"key":"498_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev-immunol-020711-075018","volume":"30","author":"S Pillai","year":"2012","unstructured":"Pillai, S., Netravali, I. A., Cariappa, A. & Mattoo, H. Siglecs and immune regulation. Annu. Rev. Immunol. 30, 357\u2013392 (2012).","journal-title":"Annu. Rev. Immunol."}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00498-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00498-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00498-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:03:21Z","timestamp":1770883401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00498-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1038\/s41413-025-00498-x","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}